Recursion Pharmaceuticals, Inc.

Cherry Creek Investment Advisors, Inc. RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/15/2026

Shares

66,677

Value ($000)

273

Weight

0.1%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/15/2026	273	0.1%	66,677	12/31/2025
2025 Q3	11/5/2025	326	0.1%	66,781	9/30/2025
2025 Q2	8/6/2025	325	0.2%	64,132	6/30/2025